Rie Horii

Summary

Affiliation: Cancer Institute Hospital
Country: Japan

Publications

  1. ncbi Spontaneous " healing" of breast cancer
    Rie Horii
    Department of Breast Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:140-4. 2005
  2. ncbi Histological features of breast cancer, highly sensitive to chemotherapy
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 14:393-400. 2007
  3. ncbi Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
    R Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Br J Cancer 97:654-8. 2007
  4. ncbi Muco-epidermoid carcinoma of the breast
    Rie Horii
    Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 56:549-53. 2006
  5. ncbi Assessment of hormone receptor status in breast cancer
    Rie Horii
    Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 57:784-90. 2007
  6. ncbi Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:233-41. 2010
  7. ncbi High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy
    Tomo Osako
    Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:1431-8. 2010
  8. ncbi Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    J Clin Oncol 26:3727-34. 2008
  9. ncbi Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
    Keiichiro Tada
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    World J Surg Oncol 8:6. 2010
  10. ncbi Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    APMIS 116:923-30. 2008

Detail Information

Publications26

  1. ncbi Spontaneous " healing" of breast cancer
    Rie Horii
    Department of Breast Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:140-4. 2005
    ..Healing is a phenomenon by which the intraductal component of breast cancer disappears and is replaced by fibrous tissue. Focally localized healing often prevents confirmation of the continuity of intraductal carcinoma...
  2. ncbi Histological features of breast cancer, highly sensitive to chemotherapy
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 14:393-400. 2007
    ..To establish tailor-made therapy for breast cancer, we investigated the possibility of predicting chemotherapy sensitive cases based on pre-therapeutic histological features...
  3. ncbi Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
    R Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Br J Cancer 97:654-8. 2007
    ..Endocrine monotherapy may be sufficient as adjuvant treatment in the intermediate-risk patients, in which only one risk factor was present without any metastatic involvement in lymph node...
  4. ncbi Muco-epidermoid carcinoma of the breast
    Rie Horii
    Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 56:549-53. 2006
    ..These histological features confirmed the diagnosis as muco-epidermoid carcinoma of the breast. This is the first report of muco-epidermoid carcinoma of the breast in Japan...
  5. ncbi Assessment of hormone receptor status in breast cancer
    Rie Horii
    Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 57:784-90. 2007
    ..When assessing hormone receptors of breast cancer in routine clinical settings, it is sufficient to determine the proportion of positive cells in the entire cancer area...
  6. ncbi Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:233-41. 2010
    ....
  7. ncbi High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy
    Tomo Osako
    Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:1431-8. 2010
    ..To determine the highly sensitive and highly resistant subsets to cytotoxic chemotherapy, we evaluated predictive factors for pCR and PD to NAC, and assessed the similarities in these factors...
  8. ncbi Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    J Clin Oncol 26:3727-34. 2008
    ..A large and systematic study is needed to address these important issues...
  9. ncbi Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
    Keiichiro Tada
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    World J Surg Oncol 8:6. 2010
    ..The impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate...
  10. ncbi Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    APMIS 116:923-30. 2008
    ..ER-beta1 itself, independent of ER-alpha expression and tamoxifen treatment, seems to have a tumor-suppressive effect, at least in apocrine carcinomas. Further study of ER-beta1 is desired to optimize breast cancer treatment...
  11. ncbi Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications
    Rin Yamaguchi
    Department of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo 135 8550, Japan
    Hum Pathol 41:679-85. 2010
    ..The presence of high-grade spindle cells in metaplastic breast carcinoma may indicate aggressive behavior...
  12. ncbi Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer 117:4365-74. 2011
    ..The authors compared the performance in intraoperative detection of sentinel lymph node metastases with OSNA assay using a whole lymph node versus routine frozen section (FS) histology with a 2 mm-sectioned lymph node...
  13. ncbi Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
    Yoshinori Ito
    Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research Breast Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan
    Cancer Sci 102:130-6. 2011
    ..However, this study suggests that a randomized phase II study is a robust tool for obtaining a rapid conclusion on the usefulness of biomarkers and could be the foundation for further large clinical trials...
  14. ncbi Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma
    Yoshimi Ide
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 61:731-6. 2011
    ..The presence of IMP components was a significant predictive factor for nodal metastasis, even if it is detected in only a small proportion of the tumor...
  15. ncbi Skin invasion and prognosis in node negative breast cancer: a retrospective study
    Keiichiro Tada
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    World J Surg Oncol 6:10. 2008
    ..The impact of skin invasion in node negative breast cancer is uncertain...
  16. ncbi Histogenesis of metaplastic breast carcinoma and axillary nodal metastases
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto ku, Tokyo, Japan
    Pathol Int 59:116-20. 2009
    ..This suggested that the ductal component metastasized to the nodes and that epithelial-mesenchymal transition subsequently occurred within the nodes...
  17. ncbi Apocrine metaplasia of breast cancer: clinicopathological features and predicting response
    Akiko Ogiya
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, Japan
    Breast Cancer 17:290-7. 2010
    ..We thus considered that apocrine metaplasia (AM) might represent a predictive marker for breast cancer...
  18. ncbi Carcinoma in a solitary intraductal papilloma of the breast
    Rin Yamaguchi
    Department of Pathology, Cancer Institute Hospital, Tokyo, Japan
    Pathol Int 59:185-7. 2009
    ..An additional partial mastectomy was performed after the lumpectomy but no carcinoma foci were noted in the excised tissue. Possible occurrence of cancerous change in solitary intraductal papilloma of the breast was suspected...
  19. ncbi A case of carcinosarcoma of the breast
    Nahomi Tokudome
    Department of Breast Pathology, The Cancer Institute, 3-10-16 Ariake, Koto-ku, Tokyo 135-8550, Japan
    Breast Cancer 12:149-53. 2005
    ..Such tumors are very rare, and there have been no detailed reports of recurrence patterns of carcinosarcoma. Here we report our pathological findings in detail...
  20. ncbi Intraductal papilloma with bloody discharge from Montgomery's areolar tubercle examined by ductoscopy from the areola
    Takehiko Sakai
    Breast Pathology Section, Cancer Institute, Japanese Foundation for Cancer Research, 3 10 6, Ariake, Tokyo 135 8550, Japan
    Breast Cancer 13:104-6. 2006
    ..Although there are a few breast carcinomas that cause bloody discharge and eruption of areola, areolar preservation should be performed with the knowledge that disease may also involve the areola through the lactiferous ducts...
  21. ncbi Therapeutic strategies for breast cancer based on histological type
    Futoshi Akiyama
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 16:168-72. 2009
    ..Histological diagnosis is also significant from the viewpoint of drug sensitivity, and it is important to maintain the accuracy of histological diagnosis...
  22. ncbi Breast cancer associated with mammary hamartoma
    Masaya Kai
    Department of Breast Surgery, Cancer Institute Hospital, 1 37 1 Ariake, Koto ku, Tokyo, Japan
    Breast Cancer 19:183-6. 2012
    ..We describe a case of invasive ductal carcinoma arising in the mammary hamartoma during the follow-up period of a previously diagnosed hamartoma...
  23. ncbi [Histological features of breast cancer as predictive factors for chemotherapy]
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research
    Nippon Rinsho 65:160-4. 2007
  24. ncbi [Evaluation of hormone receptor in breast cancers and the prognosis]
    Yuko Date
    Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research
    Nippon Rinsho 65:555-8. 2007
  25. ncbi High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer
    Masataka Sawaki
    Department of Medical Oncology, Cancer Institute Hospital and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
    Breast Cancer 13:172-8. 2006
    ..We have summarized a single-center experience involving IBC patients. Our objectives are to clarify molecular alterations of HER-2/neu and p53 in IBC and to investigate the prognostic factors...
  26. ncbi Present state of and problems with core needle biopsy for non-palpable breast lesions
    Takuji Iwase
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo 135-8550, Japan
    Breast Cancer 13:32-7. 2006
    ....